ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 355,37
1,00%
Dow Jones
42 992,21
-0,77%
DAX
19 984,32
0,74%
Brent Oil
73,44
0,00%
Bitcoin
94 483,30
0,34%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Legend Biotech Corporation (LEGN) Cours

Legend Biotech Corporation

Legend Biotech Corporation (LEGN)

NASDAQ
32,49
-0,29
(-0,88%)
Fermé 28 Décembre 10:00PM
Retardé de 15 minutes
32,49
0,00
(0,00%)
Après les heures de négociation: 1:55AM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
32,49
Prix Achat
32,20
Prix Vente
34,11
Volume échangé
797 357
32,22 Fourchette du Jour 33,31
0,00 Plage de 52 semaines 0,00
Cap du marché
5,91B
Clôture Veille
32,78
Ouverture
32,65
Dernière Transaction
1
@
34.11
Dernière heure de transaction
Volume financier
US$ 25 889 375
VWAP
32,469
Volume moyen (3 m)
-
Actions en circulation
181 911 035
Rendement du Dividende
-
Ratio Cours sur Bénéfices
0,00
Bénéfice par action (BPA)
-
Chiffre d'affairess
285,14M
Bénéfice net
-518,25M

À propos de Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treat... Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from North America. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.legendbiotech.com
Siège social
Grand Cayman, Cym
Fondé
-
Legend Biotech Corporation est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker LEGN. Le dernier cours de clôture d'Legend Biotech était de US$32,78. Au cours de la dernière année, les actions de Legend Biotech ont été négociées dans une fourchette de prix de US$ 0,00 à US$ 0,00.

Legend Biotech compte actuellement 181 911 035 actions en circulation. La capitalisation boursière d'Legend Biotech est de US$5,96 milliard.

LEGN Dernières nouvelles

Plus de nouvelles

Form 144 - Report of proposed sale of securities

26 Décembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

26 Décembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

23 Décembre 2024
Edgar (US Regulatory)

Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SOMERSET, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the...

19 Décembre 2024
GlobeNewswire Inc.

CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma

89 percent of evaluable patients achieved minimal residual disease (MRD) negativity with CARVYKTI® after three-year follow-up in CARTITUDE-4 study; the majority in less than 2 monthsResults add to...

10 Décembre 2024
GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities

02 Décembre 2024
Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans

14 Novembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

12 Novembre 2024
Edgar (US Regulatory)

Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights

CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) updates: Net trade sales of approximately $286 million, representing operational growth of 87.6% year-over-year and 53.2...

12 Novembre 2024
GlobeNewswire Inc.

Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition

SOMERSET, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a live webcast event for investors on...

07 Novembre 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

LEGN - Frequently Asked Questions (FAQ)

What is the current Legend Biotech share price?
The current share price of Legend Biotech is US$ 32,49
How many Legend Biotech shares are in issue?
Legend Biotech has 181 911 035 shares in issue
What is the market cap of Legend Biotech?
The market capitalisation of Legend Biotech is USD 5,96B
What is the 1 year trading range for Legend Biotech share price?
Legend Biotech has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the reporting currency for Legend Biotech?
Legend Biotech reports financial results in USD
What is the latest annual turnover for Legend Biotech?
The latest annual turnover of Legend Biotech is USD 285,14M
What is the latest annual profit for Legend Biotech?
The latest annual profit of Legend Biotech is USD -518,25M
What is the registered address of Legend Biotech?
The registered address for Legend Biotech is 4TH FLOOR, HARBOUR PLACE, 103 SOUTH CHURCH STREET, PO BOX 10240, GRAND CAYMAN, KY1 1002
What is the Legend Biotech website address?
The website address for Legend Biotech is www.legendbiotech.com
Which industry sector does Legend Biotech operate in?
Legend Biotech operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
INTZIntrusion Inc
US$ 2,167
(381,56%)
187,57M
AILEiLearningEngines Inc
US$ 0,5932
(267,31%)
557,72M
HUBCWHub Cyber Security Ltd
US$ 0,035
(250,00%)
2,65M
GTIGraphjet Technology
US$ 0,967551
(185,83%)
398,75M
LITMSnow Lake Resources Ltd
US$ 1,61
(82,95%)
129,92M
NEUPNeuphoria Therapeutics Inc
US$ 4,11
(-92,30%)
936,47k
VIRXViracta Therapeutics Inc
US$ 0,16
(-32,49%)
9,31M
PRFXPainReform Ltd
US$ 3,48
(-28,98%)
926,19k
AIREreAlpha Tech Corporation
US$ 2,56
(-28,49%)
8,26M
AVGRAvinger Inc
US$ 0,9721
(-24,05%)
2,11M
AILEiLearningEngines Inc
US$ 0,5932
(267,31%)
563,26M
GTIGraphjet Technology
US$ 0,967551
(185,83%)
398,95M
RGTIRigetti Computing Inc
US$ 17,08
(10,62%)
305,79M
XTIAXTI Aerospace Inc
US$ 0,03935
(-1,63%)
268M
QSIQuantum Si Inc
US$ 3,585
(66,74%)
256,01M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
LEGN
Legend Biotech
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés